[Federal Register Volume 87, Number 53 (Friday, March 18, 2022)]
[Notices]
[Pages 15433-15435]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-05753]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-22-1150; Docket No. CDC-2022-0035]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a proposed 
information collection project titled Generic Clearance for Lyme and 
other Tickborne Diseases (TBD) Knowledge, Attitudes, and Practices 
(KAP) Surveys. This data collection involves the administration of a 
set of surveys designed to understand KAPs related to prevention of 
Lyme and other TBDs and to inform implementation of future TBD 
prevention interventions.

DATES: CDC must receive written comments on or before May 17, 2022.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0035 by either of the following methods:
     Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS H21-8, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (regulations.gov) or by U.S. mail to the address listed above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS

[[Page 15434]]

H21-8, Atlanta, Georgia 30329; phone: 404-639-7570; Email: [email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected;
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses; and
    5. Assess information collection costs.

Proposed Project

    Generic Clearance for Lyme and other Tickborne Diseases (TBD) 
Knowledge, Attitudes, and Practices (KAP) Surveys (OMB Control No. 
0920-1150, Exp. 9/30/2022)--Revision--National Center for Emerging and 
Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    The Centers for Disease Control and Prevention (CDC) Division of 
Vector-Borne Diseases (DVBD) and other programs working on tickborne 
diseases (TBDs) are requesting a Revision to a previously approved 
generic clearance to conduct TBD prevention studies to include 
knowledge, attitudes, and practices (KAP) surveys TBDs among residents 
and businesses offering pest control services in Lyme disease endemic 
areas of the United States. The data collection for which approval is 
sought will allow DVBD to use survey results to inform implementation 
of future TBD prevention interventions. The Revision involves a 
broadening of the secondary target population from owners and employees 
of pest control companies to stakeholders of local entities affected by 
TBDs (e.g., leaders in local public health or local government; owners 
or employees of pest control companies, landscaping companies, or other 
at-risk occupations; non-governmental organizations serving at-risk 
populations; and/or clinicians serving at-risk populations).
    TBDs are a substantial and growing public health problem in the 
United States. From 2004-2016, over 490,000 cases of TBDs were reported 
to CDC, including cases of anaplasmosis, babesiosis, ehrlichiosis, Lyme 
disease, Rocky Mountain spotted fever, and tularemia. Lyme disease 
accounted for 82% of all TBDs, with over 400,000 cases reported during 
this time period. Recent studies estimate nearly 500,000 cases of Lyme 
disease are diagnosed annually in the United States. In addition, 
several novel tickborne pathogens have recently been found to cause 
human disease in the United States. Factors driving the emergence of 
TBDs are not well defined and current prevention methods have been 
insufficient to curb the increase in cases. Data is lacking on how 
often certain prevention measures are used by individuals at risk as 
well as what the barriers to using certain prevention measure are.
    The primary target population for these data collections are 
individuals and their household members who are at risk for TBDs 
associated with I.scapularis ticks and who may be exposed to these 
ticks residentially, recreationally, and/or occupationally. The 
secondary target population includes stakeholders of local entities 
affected by TBDs (e.g., leaders in local public health or local 
government; owners or employees of pest control companies, landscaping 
companies, or other at-risk occupations; non-governmental organizations 
serving at-risk populations; and/or clinicians serving at-risk 
populations) in areas where I. scapularis ticks transmit diseases to 
humans. Specifically, these target populations include those residing 
or working in the 15 highest incidence states for Lyme disease (CT, DE, 
ME, MD, MA, MN, NH, NJ, NY, PA, RI, VT, VA, WI and WV). We anticipate 
conducting one to two surveys per year, for a maximum of six surveys 
conducted over a three-year period. Depending on the survey, we aim to 
enroll 500-10,000 participants per study. It is expected that we will 
need to target recruitment to about twice as many people as we intend 
to enroll. Surveys may be conducted daily, weekly, monthly, or bi-
monthly per participant for a defined period (whether by phone or web 
survey), depending on the survey or study. The surveys will range in 
duration from approximately 5-30 minutes. Each participant may be 
surveyed 1-64 times in one year; this variance is due to differences in 
the type of information collected for a given survey. Specific burden 
estimates for each study and each information collection instrument 
will be provided with each individual project submission for OMB 
review.
    Insights gained from KAP surveys will aid in prioritizing which 
prevention methods should be evaluated in future randomized, controlled 
trials and ultimately help target promotion of proven prevention 
methods that could yield substantial reductions in TBD incidence. CDC 
requests OMB approval for an estimated 98,830 annual burden hours. 
There is no cost to respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                                     Number of       Number of      burden per     Total  burden
      Type of respondent            Form name       respondents    responses per   response  (in       hours
                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
General public, individuals or  Screening                 20,000               1           15/60           5,000
 households.                     instrument.
                                Consent form....          10,000               1           20/60           3,330
                                Introductory              10,000               1           30/60           5,000
                                 Surveys.

[[Page 15435]]

 
                                Monthly surveys.          10,000              12           15/60          30,000
                                Final surveys...          10,000               1           30/60           5,000
                                Daily surveys...          10,000              60           10/60          50,000
Stakeholders of local entities  Stakeholder                1,000               1           30/60             500
 affected by TBDs.               Survey.
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............          98,830
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-05753 Filed 3-17-22; 8:45 am]
BILLING CODE 4163-18-P